top of page

SESSIONS OVERVIEW

HALL A
(CLINICAL COMMUNICATIONS)

08:00-08:30 REGISTRATION

08:30-10:00 INAUGURAL SESSION:(AMPHITHEATER)

            Pr. Jean Marc Ayoubi (FR), Pr. Botros Rizk (USA)

               KEYNOTE LECTURE

              Samir Hamamah (FR) - Worldwide strategy for fighting infertility

10:30-12:00 SESSION 1A:INFERTILITY–PREVALENCE AND ETHNICITY
            Chair:
PE. Bouet*
                                      Hassan Salam (EG) - The changing Face of assistance reproduction from rock-start doctors to bland Brands.

                                                    Luigi Montano (IT) - Environmental Impact on Fertility. The EcoFoodFertility Research Project: A Study Model  for Polluted Areas                                                                                                     of   the World 

                                                   Minguez Alarcon, Lidia (US) - Chemical and Non-Chemical Stressors and Infertility Treatment Outcomes 

12:00-13:00  SESSION 2A:INNOVATION AND RIGHT TO ACCESS THE ART

             Chairs:Sofiane Bendifallah, Samir Hamamah (FR)

                                          Johnny S. Younis (IL) - The Pros and Cons of Endometriotic Cystectomy in the Reproductive Age:

                                                                                                           A Critical Appraisalof the Quality of Evidence

                                                     Stephane Viville (FR) - Genetics of Infertility: A Paradigm Shift for Medically Assisted Reproduction​

​

13:00-14:00 SYMPOSIUM–ART:COST AND EFFICIENCY

                                    Thomas D’Hooghe (DE) - Guidelines for IVF Centers to Provide High Quality Data for Real World                                                                                    Data Research 

14:00-15:00 SESSION 3A:ENDOMETRIOSIS
            Chair:

                                                           Antonio D’Amato (IT) - Can the Addition of Corticosteroid to Antibiotic Therapy for Chronic Endometritis in Women with                                                                                                                             Recurrent Implantation Failure Improve Their Reproductive Outcomes?
                                                           Sofiane Bendifallah (FR) - Non-Invasive Test for Early Diagnosis

15:00-18:00 SESSION 4A:POOR OVARIAN RESPONSE-PREDICTORS AND MANAGEMENT
            Chair:
Fréderic Lamazou* (FR)
                                                       Peter Kovacs (HU) - Should We Consider ‘Milder’ Stimulation for Poor Responders Undergoing IVF?
                                                       
Hassan Sallam (EG) - Can We Really Use Ovarian Reserve Markers As A Guide to Ovarian Stimulation?
                                                       
Aref Maddahi (IR) - Evaluvation of Various Drugs in the Treatment of Fertility Due to Poor Ovarian Reserve
                                                      Thomas D’Hooghe (DE) - Beyond FORT and FOI: New Key Performance Indicators to Assess Efficiency of Ovarian Stimulation                                                                                                                    for ART in Women with Poor Ovarian Reserve ( Alternative Title: Added Value of rFSH : rLH                                                                                                                                    Cotreatment in Poor Ovarian Responders: What is the Evidence? )

                                                      Yassir Ait benkaddour (MAR) - Conventional Controlled Ovarian Stimulation - Protocols for Diminished Ovarian Reserve
                                                                                                                          Patients and Poor Responders

HALL B
(CLINICAL COMMUNICATIONS)

​10:30-11:30 SESSION 1B:POLYCYSTIC OVARY SYNDROME(PCOS)
            Chairs:
Anne Bachelot*,  Sophie Christin Maître*
                                                        Christine Decanter (FR) - PCOS in IVF: How to Stimulate? Strong or Soft?
                                                        Abbara Ali (UK) - Kisspeptin and Infertility​

11:30-12:30 SESSION 2B:WHAT CONTROL ON OVARIAN STIMULATION PROTOCOLS                Chairs:Nathalie Massin*, Sophie Christin Maitre* 

                                         Sevcan (fata) Ozozturk (NL) - New Algorithms for Predicting the Chance of IVF Treatment Success                                                                  Nathalie Massin* (FR) - Place of AI in ART

12:30-13:00 SYMPOSIUM/LUNCH
14:00-16:00 SESSION 3B:MEDICAL AND EMBRYOLOGICAL QUALITY IN IVF CENTERS
            Chair:Marine Poulain*
                                                    Waleed Marie (BE) - Safegarding Embryo Quality and Offspring Health: Lessons From Humans’ Studies and
                                                                                                    Pathophysiological Animal Models
                                             
      Andrea Etrusco (IT) - Impact of Adenomyosis on IVF Outcomes
                                                   
AÅŸina Bayram (UAE) - Which Variabled Have An Impact on the Clinical Pregnancy Rate?
                                                   
Marine Poulain (Fr) - Child Health Issued From ART

16:30-18:00 SESSION 4B:UP TO DATE DIAGNOSIS OF INFERTILITY
            Chair:
Marie Carbonel*
                                      Celia Ravel (FR) - Ovarian Extracellular Vesicles: New Markers of Female Fertility
                                      Christine Decanter (FR) - Clinical Utility of AMH Measurement in Reproductive Medicine
                                      To Be Annonced

08:00-08:30 REGISTRATION AND WELCOME
09:00-10:00 SESSION 1C:THE FIVE STEPS TO CREATE AN IVF CENTER
10:00-10:30 COFFEE BREAK
10:30-11:30 SESSION 2C:DEVELOPMENT OF AN IVF CENTER - ORGANIC GROWTH
11:30-12:30 SESSION 3C:DEVELOPMENT OF AN IVF CENTER - EXTERNAL GROWTH
13:00-14:00 LUNCH AND SYMPOSIUMS
14:00-15:00 SESSION 4C:FINANCIAL ASPECTS OF AN IVF CENTER
15:00-16:00 SESSION 5C:VALUE OF AN IVF CENTER
16:00-17:00 SESSION 6C:TRANSMITTING PERENNATION OF AN IVF CENTER
17:00-17:30 CONCLUSIONS

HALL B
(CLINICAL COMMUNICATIONS)

bottom of page